Catalyst Wire Dossier Catalyst Wire Dossier

Alvimopan

alvimopan · Eisai Co., Ltd.
Drug timelines are a Plus or Pro feature.

20 regulatory and trial events tracked for Alvimopan, covering 2015-07-02 to 2025-09-23. Get the full timeline:

Most recent: FDA Approved: ALVIMOPAN — Supplemental Application (Par Health USA, LLC)

See pricing